Hims & Hers Health, Inc.
—- Market cap
- —
- Debt
- +$1.34B
- Cash
- −$228.62M
Complete market value, debt and cash evidence is required for enterprise value.
Compare price, profitability, solvency, and SEC-reported financials side by side—before deciding which assumptions deserve a closer look.
Decision snapshot: HIMS stock price vs FRT: inconclusive Relative valuation is incomplete for this pair. Review the available filing metrics before drawing a conclusion.
Quick read
Each company valued on the other's multiple, then compared with the market price.
Implied fair value · at FRT's multiple
Needs FRT P/E.
Implied fair value · at HIMS's multiple
Needs HIMS P/E.
Metric by metric
Price unavailable
Where each company leads, and how wide the gap is.
Growth edge
Pricing power
Operating leverage
Lower is better
Not comparable
Lower leverage
Statements
Core statements aligned to each company's latest fiscal year.
SEC periods: HIMS FY 2025 (ended Dec 31, 2025) · FRT FY 2025 (ended Dec 31, 2025).
Trendline
Five fiscal years of revenue, earnings, and margins before underwriting a re-rating.
Price framework
Market cap plus debt, less cash.
Complete market value, debt and cash evidence is required for enterprise value.
Complete market value, debt and cash evidence is required for enterprise value.
Price framework
The same filing-backed model used on each company's valuation page, with company-specific inputs and calculated scenarios.
HIMS & HERS HEALTH, INC. · implied price per share
Debt and bridge-cash inputs are required to translate enterprise value into equity value.
FEDERAL REALTY INVESTMENT TRUST · implied price per share
Five annual free-cash-flow observations are required for the filing-backed baseline.
Balance sheet health
Financial health checks to separate durable balance sheets from potential value traps.
Financial strength on a 0–9 scale.
Bankruptcy-risk signal from balance sheet and earnings power.
Not enough data to score either balance sheet.
Debt / equity
Total debt against shareholders' equity
2.48x
1.52x
Net debt / EBITDA
Leverage against operating earnings
7.55x
6.31x
Cash and equivalents
Liquid reserves on the balance sheet
$228.62M
$107.42M
Total debt
Interest-bearing obligations outstanding
Comparable set
Where the pair sits against the wider comparable set.
Keep comparing
Open adjacent comparisons from the same industry to pressure-test the read across multiple pairs.
Teladoc Health, Inc.
HIMS vs TDOC
GoodRx Holdings, Inc.
HIMS vs GDRX
CLOVER HEALTH INVESTMENTS, CORP. /DE
HIMS vs CLOV
Roivant Sciences Ltd.
HIMS vs ROIV
KIMCO REALTY CORP
HIMS vs KIM
REGENCY CENTERS CORP
HIMS vs REG
Brixmor Property Group Inc.
HIMS vs BRX
SIMON PROPERTY GROUP INC /DE/
HIMS vs SPG
$1.34B
$4.94B
LLM-powered synthesis
An explanation of the financial evidence. Check its snapshot date against the figures above.
The deterministic comparison remains available. Sign in when you want an on-demand narrative synthesis of the same data.